Tumor-derived extracellular vesicle proteins as new biomarkers and targets in precision oncology
Journal of Molecular Medicine · 2024
DOI: 10.1007/s00109-024-02452-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Molecular Medicine, 2024. Verfasst von Haiyan Liao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Shenzhen Key Laboratory of Gastrointestinal Cancer Translational Research, Cancer Institute, Peking University Shenzhen Hospi…. Hauptthemen laut MEDLINE: Extracellular Vesicles, Precision Medicine, Biomarkers, Tumor, Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Extracellular vesicles (EVs) are important carriers of signaling molecules, such as nucleic acids, proteins, and lipids, and have become a focus of increasing interest due to their numerous physiological and pathological functions. For a long time, most studies on EV components focused on noncoding RNAs; however, in recent years, extracellular vesicle proteins (EVPs) have been found to play important roles in diagnosis, treatment, and drug resistance and thus have been considered favorable biomarkers and therapeutic targets for various tumors. In this review, we describe the general protocols of research on EVPs and summarize their multifaceted roles in precision medicine applications, including cancer diagnosis, dynamic monitoring of therapeutic efficacy, drug resistance research, tumor microenvironment interaction research, and anticancer drug delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Shenzhen Key Laboratory of Gastrointestinal Cancer Translational Research, Cancer Institute, Peking University Shenzhen Hospital, Shenzhen-Peking University-Hong Kong University of Science and Te…
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Oncology, Peking University Cancer Hospital and Institute, Beijing, China.
- Chi Biotech Co., Ltd., Shenzhen, China.
ORCID-Profile: Haiyan Liao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liao, H., Zhang, C., Wang, F., Jin, F., Zhao, Q., Wang, X., Wang, S., & Gao, J. (2024). Tumor-derived extracellular vesicle proteins as new biomarkers and targets in precision oncology. Journal of Molecular Medicine. https://doi.org/10.1007/s00109-024-02452-6
Vancouver
Liao H, Zhang C, Wang F, Jin F, Zhao Q, Wang X, et al. Tumor-derived extracellular vesicle proteins as new biomarkers and targets in precision oncology. Journal of Molecular Medicine. 2024. doi:10.1007/s00109-024-02452-6
BibTeX
@article{Liao2024,
author = {Liao, Haiyan and Zhang, Cheng and Wang, Fen and Jin, Feng and Zhao, Qiqi and Wang, Xinying and Wang, Shubin and Gao, Jing},
title = {Tumor-derived extracellular vesicle proteins as new biomarkers and targets in precision oncology},
journal = {Journal of Molecular Medicine},
year = {2024},
doi = {10.1007/s00109-024-02452-6}
}
EUVIMED